Shares in US drug major Eli Lilly were a hefty 8% down early Thursday after the Indianapolis firm announced its first quarter financial results and latest guidance for 2025.

Moderna logged a first-quarter loss as revenue fell, dragged down by lower product sales, though the company said it expects ...

Moderna, the bloodied Covid-era prizefighter of the healthcare sector, stumbles toward its next earnings report on Thursday ...

By MICHELLE CHAPMAN and ANNE D'INNOCENZIO AP Business Writer Kohl’s has terminated its new CEO Ashley Buchanan after an ...

Enterprise Products Partners excels in passive income generation, capital stewardship, and offers a potential 14% annual ...

McDonald’s has reported its biggest sales drop since the pandemic as customers in the U.S. are concerned about the economy ...

Xcel Energy is just three years away from becoming a Dividend Aristocrat. Find out why I'm maintaining my buy rating for now ...

Rezdiffra™ (resmetirom) net sales of $137.3 million As of March 31, 2025, more than 17,000 patients on Rezdiffra Two-year compensated MASH cirrhosis (F4c) data from MAESTRO-NAFLD-1 trial selected as ...